May 4, 2024Open Access

Utility of neutrophil-to-lymphocyte ratio as an indicator of tumor immune status in non-small cell lung cancer

Key Points

Key points are not available for this paper at this time.

Abstract

Neutrophil-to-lymphocyte ratio (NLR) has been reported as a prognostic biomarker in non-small cell lung cancer (NSCLC); however, the underlying biological rationale remains unclear. The present study aimed to explore the potential utility of NLR as a surrogate biomarker for immune response to cancer and to elucidate the underlying mechanism.

Read Full Paperexternally

Demander à l'IA

Bookmark

View Full Paper

Cite This Study

Iwata et al. (Sat,) studied this question.

synapsesocial.com/papers/68e6b91fb6db643587639c12 https://doi.org/https://doi.org/10.1093/jjco/hyae058

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Tumor-associated neutrophils (TAN) develop pro-tumorigenic properties during tumor progression2013 · 358 citations
2Origin and physiological roles of inflammation2008 · 6,400 citations
3Local and Systemic Inflammatory Markers as Prognostic and Predictive Markers In Locally Advanced Triple Negative Breast Cancer2020 · 4 citations
4Quantitative and Spatial Analysis of CD8+/PD-1 Tumor-Infiltrating Lymphocytes as a Predictive Biomarker for Clinical Response of Melanoma In-Transit Metastases to Topical Immunotherapy2020 · 8 citations
5Immune-resistant mechanisms in cancer immunotherapy2020 · 66 citations

Demander à l'IA

Bookmark

View Full Paper